Showing results (151-160 of 408) with videos related to
Sort By:
Pageof 41
Journal of Biopharmaceutical Statistics|September 18, 2015
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic reviewThomas Ondra, Alex Dmitrienko, Tim Friede, et al.Journal of Alzheimer'S Disease : JAD|August 16, 2014
Cerebrospinal fluid apolipoprotein E concentration and progression of Alzheimer's diseaseChristian Schmidt, Nicole Gerlach, Christoph Peter, et al.Biometrical Journal. Biometrische Zeitschrift|March 22, 2017
Dose-finding methods for Phase I clinical trials using pharmacokinetics in small populationsMoreno Ursino, Sarah Zohar, Frederike Lentz, et al.BMC Anesthesiology|October 31, 2013
Prognosis of AKI in malignant diseases with and without sepsisMalte Heeg, Alexander Mertens, David Ellenberger, et al.Pain|June 4, 2016
Back schools for the treatment of chronic low back pain: possibility of benefit but no convincing evidence after 47 years of research-systematic review and meta-analysisSebastian Straube, Markus Harden, Heiko Schröder, et al.Plos One|October 18, 2017
Predictors of mortality and ICD shock therapy in primary prophylactic ICD patients-A systematic review and meta-analysisLeonard Bergau, Tobias Tichelbäcker, Barbora Kessel, et al.Plos One|February 7, 2015
Regression to the mean and predictors of MRI disease activity in RRMS placebo cohorts--is there a place for baseline-to-treatment studies in MS?Jan-Patrick Stellmann, Klarissa Hanja Stürner, Kim Lea Young, et al.BMC Health Services Research|May 29, 2026
Does an app make patients happy? Impact of a novel medical history app on patient satisfaction in urgent care consultations in Germany: cluster-randomized interventional trial 'DASI'Eva Maria Noack, Kai Antweiler, Frank Müller, et al.Therapeutic Innovation & Regulatory Science|July 14, 2023
Application of Statistical Methods for Central Statistical Monitoring and Implementations on the German Multiple Sclerosis RegistryFiras Fneish, David Ellenberger, Niklas Frahm, et al.Journal of Biopharmaceutical Statistics|November 9, 2010
Perspectives on the use of adaptive designs in clinical trials. Part II. Panel discussionNorbert Benda, Werner Brannath, Frank Bretz, et al.Pageof 41